Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca vaccine Post date 6 May 2021 ← Enhancing UK action and promoting equity of access to global covid-19 vaccines → Thromboembolism and the Oxford-AstraZeneca vaccine